Skip to Content Skip to Navigation

Clinical Research

The Emerald Clinics Research Model – where care meets data

Care Programs

Program NameSponsorIndicationDescriptionStatus
Autism Observational StudyZelira TherapeuticsAutismAn open label, observational study to investigate the tolerance and response to two low dose medicinal cannabis products with different THC:CBD ratios in Autism Spectrum Disorder (ASD) patients .Open now for recruitment

Expression of interest form

Calm Gut StudyEmyriaIBSAn open-label, observational study to investigate efficacy and safety of routinely prescribed oral medicinal cannabis for management of symptoms in patients with irritable bowel syndrome (IBS).Open now for recruitment

Expression of interest form

Emerald Care ModelEmyriaAll indicationsA real world data registry, tracking responses to novel treatments for patients with unmet medical needs.Open
Qualitative SurveyUniversity of Western AustraliaPalliative CareMedicinal cannabis access among palliative care patients: The experience of patients and their carersOpen
Zenivol pharmacovigilence programZelira TherapeuticsInsomniaA program to evaluate the safety and tolerability of Zelira's Zenivol oil formulation in adult patients with symptoms of insomniaOpen
Medicinal Cannabis and DementiaMCG PharmaceuticalsDementiaMedicinal cannabis and dementia: Examining its benefits among older residential care recipients. A placebo controlled randomised, double blinded crossover N-of-1 clinical trial.Open - see further details
Opioid Sparing Clinical TrialZelira TherapeuticsChronic Pain

An open label study to evaluate the safety, tolerability, and pharmacokinetics of a medicinal cannabinoid oil formulation in chronic non-cancer pain patients


At Emerald Clinics, we believe that we can provide the best care to our patients when we listen to them. Learn from them. And then, with these learnings, use that newly generated knowledge – or “real world evidence” – to inform future care.

We integrate structured research data collection into each of our patient visits, so that we can make meaningful comparisons of our patient’s progress. We don’t just guess or hope that a novel treatment will work – we take a structured scientific approach to understanding each new treatment, so that our patients receive the best care possible.

This is our standard.

Our Research Interests

At Emerald Clinics, our research is focused around finding new and better treatment for patients with unmet medical needs. That is to say, where patients haven’t yet found success in treating their condition, despite trying all available conventional treatment.

Unmet medical needs of interest include:



Symptoms related to Chemotherapy


Irritable Bowel Syndrome


Neurological Spasticity

Parkinson’s Disease

Migraine / Headache

Alzheimer’s Disease


Inflammatory Bowel Disease


Depression and Anxiety

Palliative Care